A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa

Hypertension Clinical Trial

— SAPPHIRE  

Official title:

A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT04810650
• Other study ID #: SAPPHIRE
• Secondary ID: U01AI150510
• Status: Active, not recruiting
• Phase: N/A
• Start date: April 15, 2021
• Est. completion date: September 2024

Study information

• Verified date: May 2023
• Source: University of California, San Francisco
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The randomized trials in this record will assess effectiveness, fidelity and cost of prevention and treatment interventions for HIV and hypertension with the objective of informing a population-based study of multi-sectored, multi-disease interventions for HIV.

Description:

The study will conduct randomized trials to assess effectiveness, fidelity and cost of prevention and treatment interventions. The study will conduct two randomization trials to evaluate dynamic treatment interventions tailored to the needs of heavy alcohol users and mobile populations. The study will conduct three randomized trials to evaluate dynamic choice prevention interventions delivered in the context of antenatal clinics, the outpatient department, and in the community delivered by village health teams. The trial will conduct a randomized trial to evaluate a linkage intervention for patients with hypertension and a randomized trial to evaluate a clinic vs. community based intervention for hypertension.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 3000
• Est. completion date: September 2024
• Est. primary completion date: September 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 15 Years and older

Eligibility

INDIVIDUAL LEVEL INCLUSION CRITERIA FOR COMPONENT INTERVENTIONS PrEP/PEP at Outpatient Clinics

1. Age =15 years

2. HIV-negative

3. Current or anticipated risk for HIV-infection PrEP/PEP at Antenatal Clinics

1. Age =15 years

2. HIV-negative

3. Current or anticipated risk for HIV-infection PrEP/PEP at Community Households

1. Age > 15 years

2. HIV-negative

3. Current or anticipated risk for HIV-infection Mobility Dynamic Treatment Intervention

1. Age =15 years

2. HIV-positive

3. HIV RNA non-suppression (>400 c/mL in the prior 12 months) or missed 2 visits in past 12 months or missed 2 visits in past 12 months or no VL measured in past 12 months

4. Travel outside the community =2 times in past 12 months

5. Enrolled or new to care in a study clinic Healthy Living Intervention for Heavy Alcohol Users

1. Age =18 years

2. HIV-positive

3. HIV RNA non-suppression (>400 c/mL in the prior 12 months) or missed clinic visits (>2 weeks or <=90 days from last scheduled clinic visit) within past 6 months, or out of care without return to care (>90 days from last scheduled clinic visit) within past 6 months

4. Heavy alcohol use per AUDIT-C tool (scores of =4 for men, and =3 for women)

5. Enrolled or new to care in a study clinic Hypertension Linkage Intervention

1. Age =25 years

2. Blood pressure =140/90 mmHg on three repeated measurements during community-based hypertension screening

3. Resident (by self-report) within catchment area of referral health center Community Hypertension Intervention

1. Age >=40

2. Blood pressure =160/100 on average of 2nd and 3rd measurements at initial screening

3. Sustained blood pressure elevation to =140/90 at initial clinic enrollment visit INDIVIDUAL LEVEL EXCLUSION CRITERIA FOR COMPONENT INTERVENTIONS PrEP/PEP at Outpatient Clinics

1. <15 years of age

2. Unable to provide consent or parental co-consent as per country guidelines

3. Participation in another Phase A RCT intervention component PrEP/PEP at Antenatal Clinics

1. <15 years of age

2. unable to provide consent or parental co-consent as per country guidelines

3. Participation in another Phase A RCT intervention component PrEP/PEP at Community Households

1. <15 years of age

2. unable to provide consent or parental co-consent as per country guidelines

3. Participation in another Phase A RCT intervention component Mobility Dynamic Treatment intervention

1. <15 years of age

2. Participation in another Phase A RCT intervention component Healthy Living Intervention for Heavy Alcohol Users

1. <18 years of age

2. Participation in another Phase A RCT intervention component

3. No access to mobile phone Hypertension Linkage Intervention

1. <25 years of age

2. Plan to out-migrate from the catchment area of referral health center within 30 days of screening visit

3. Already engaged in hypertensive care (by self-report)

4. Blood pressure measure of =180/110 mmHg during screening symptoms of hypertensive emergency Community Hypertension Intervention

1. Pregnancy

2. Co-morbidities that preclude home monitoring

Related Conditions & MeSH terms

• Alcohol Drinking
• Cost Effectiveness
• HIV
• Hypertension
• Maternal Child Health

Intervention

Other:
• Mobility Dynamic Treatment Intervention
1) Access to a mobility coordinator who will assist with transfers, rescheduling, and out-of-facility refills; 2) Provision of a "travel pack" with alternative ART packaging options (e.g. ziplock bags, envelopes, pill boxes), a packing list and mobility coordinator phone contact for unplanned travel; 3) Screening at every clinic visit for planned mobility; 4) Mobile number and mobile minutes for unexpected travel; 5) Provision of longer refills (up to 6-months) for planned travel
• Health Living Intervention for Heavy Alcohol Users
1) Two in-person alcohol counseling sessions with support from a clinical psychologist; 2) Monthly booster phone calls
• Hypertension Linkage
1) Travel voucher (financial incentive) conditional on linkage to hypertensive care; 2) Phone call reminders for missed visits
• PrEP/PEP at Outpatient Clinics
Intervention delivered at Outpatient Clinics: Counseling and education on and choice between prevention modalities (e.g. PrEP, PEP, condoms), choice of service location, provision of a clinical officer's or nurse's mobile telephone number for immediate PEP starts any day of the week, routine assessment of barriers to initiation or adherence to PrEP/PEP, including the offer of personalized potential solutions such as choice of in-clinic or offsite service delivery, psychologic supports for traumatic experiences, and offer of concurrent, additional health or prevention related services
• PrEP/PEP at Antenatal Clinics
Intervention delivered at Antenatal Clinics: Counseling and education on and choice between prevention modalities (e.g. PrEP, PEP, condoms), choice of service location, provision of a clinical officer's or nurse's mobile telephone number for immediate PEP starts any day of the week, routine assessment of barriers to initiation or adherence to PrEP/PEP, including the offer of personalized potential solutions such as choice of in-clinic or offsite service delivery, psychologic supports for traumatic experiences, and offer of concurrent, additional health or prevention related services
• PrEP/PEP at Community Households
Intervention delivered in community by village health team: Counseling and education on and choice between prevention modalities (e.g. PrEP, PEP, condoms), choice of service location, provision of a clinical officer's or nurse's mobile telephone number for immediate PEP starts any day of the week, routine assessment of barriers to initiation or adherence to PrEP/PEP, including the offer of personalized potential solutions such as choice of in-clinic or offsite service delivery, psychologic supports for traumatic experiences, and offer of concurrent, additional health or prevention related services
• Standard of Care
Local country standard of care protocols
• Hypertension Community
Hypertension care delivered at home with clinician telehealth, facilitated by lay health worker to measure blood pressure and deliver medications

Locations

Country	Name	City	State
Kenya	GPRT / SEARCH Office	Kisumu
Uganda	IDRC Southwest Uganda	Mbarara

Sponsors (11)

Lead Sponsor

Collaborator

University of California, San Francisco

Infectious Diseases Research Collaboration, Uganda, Kenya Medical Research Institute, Makerere University, National Heart, Lung, and Blood Institute (NHLBI), National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Mental Health (NIMH), National Institute on Alcohol Abuse and Alcoholism (NIAAA), University College, London, University of California, Berkeley, University of Pennsylvania

Countries where clinical trial is conducted

Kenya,  Uganda, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Prevention coverage defined as proportion of follow-up weeks at risk that the participant is protected from HIV infection with either PrEP or PEP	Primary outcome for comparison for PrEP/PEP Dynamic Prevention Intervention at outpatient clinics vs. PrEP/PEP standard of care at outpatient clinics (not applicable to other arms). Primary definition of coverage will rely on self report.	48 weeks
Primary	Prevention coverage defined as proportion of follow-up weeks at risk that the participant is protected from HIV infection with either PrEP or PEP	Primary outcome for comparison for PrEP/PEP Dynamic Prevention Intervention at antenatal clinics vs. PrEP/PEP standard of care at antenatal clinics (not applicable to other arms). Primary definition of coverage will rely on self report.	48 weeks
Primary	Prevention coverage defined as proportion of follow-up weeks at risk that the participant is protected from HIV infection with either PrEP or PEP	Primary outcome for comparison for PrEP/PEP Dynamic Prevention Intervention at community households vs. PrEP/PEP standard of care at community households (not applicable to other arms). Primary definition of coverage will rely on self report.	48 weeks
Primary	Number of participants with viral suppression defined by HIV RNA<400 cps/ml	Primary outcome for comparison of Mobility Dynamic Treatment intervention vs. standard of care control (not applicable to other arms). Data collected from medical records.	48 weeks
Primary	Number of participants with viral suppression defined by HIV RNA<400 cps/ml	Primary outcome for comparison of Healthy Living Intervention for Heavy Alcohol Users vs. standard of care control (not applicable to other arms). Data collected from medical records.	24 weeks
Primary	Number of participants to linked to hypertension care	Primary outcome for comparison of Hypertension linkage intervention vs. hypertension linkage control (not applicable for other arms). Linkage to hypertension care at the local government clinic within 30 days of screening positive for high blood pressure during community screening. The primary definition will rely on clinical records.	30 days
Primary	Proportion of participants with hypertension control <140/90 mmHg	Primary outcome for hypertension community treatment intervention vs. hypertension community treatment control (not applicable for other arms). Blood pressure will be measured three times using standardized procedures in all trial participants at the 24-week study visit. Hypertension is considered controlled if the average of the 2nd and 3rd measures <140 mmHg systolic and <90 mmHg diastolic.	24 weeks

External Links

•   SEARCH